Physician profile
Bridgette Wilson
NPI 1023593373
$1,843.14
in general payments reported to CMS, 2019-2025
17 companies · $889 in 2025
The $889 reported for 2025 was more than what 78% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $565 · 2022: $282 · 2024: $108 · 2025: $889.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $997.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $996.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $452.55 | 2021-2025 | |
| Alkermes, INC. | $314.25 | 2021-2025 | Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $209.44 | 2021-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $173.29 | 2022-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $105.49 | 2025 | Invega Sustenna, Spravato |
| Supernus Pharmaceuticals, INC. | $91.73 | 2024 | Qelbree |
| Noven Therapeutics, LLC | $89.29 | 2025 | Xelstrym |
| Axsome Therapeutics, INC. | $88.39 | 2025 | Auvelity |
| Tris Pharma INC | $64.70 | 2025 | Dyanavel Xr |
| Corium, LLC | $59.71 | 2025 | Azstarys |
| E.R. Squibb & Sons, L.L.C. | $45.08 | 2025 | Cobenfy |
| Almatica Pharma LLC | $42.13 | 2025 | Loreev Xr |
| Neurocrine Biosciences, INC. | $24.61 | 2022 | |
| Boston Scientific Corporation | $24.29 | 2025 | General - Atherectomy |
| Eisai INC. | $22.41 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $18.01 | 2025 | Trintellix |
| Collegium Pharmaceutical, INC. | $17.77 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridgette Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.